Aarti Drugs Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AARTIDRUGS.BO | IOLCP.NS | INDSWFTLAB.NS | THEMISMED.NS | AAREYDRUGS.NS | 600420.SS | |
|---|---|---|---|---|---|---|
| Market cap | 40.55B | 55.50B | 31.52B | 9.44B | 3.49B | 11.21B |
| P/E (TTM) | 21.2 | 27.3 | 37.0 | 23.5 | 74.4 | 24.6 |
| Forward P/E | 15.9 | 17.5 | — | — | — | 8.1 |
| Price/book | 2.6 | 2.9 | 2.1 | 2.4 | 2.1 | 0.8 |
| Dividend yield | 0.43% | 0.54% | — | 0.50% | — | 2.98% |
| 1-year change | −4.81% | +87.93% | +240.08% | −15.70% | +10.12% | −19.19% |
| Today | −2.23% | +2.89% | −3.72% | +2.13% | +0.08% | −0.24% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All AARTIDRUGS.BO news ›Aarti Drugs Q2 EBITDA rises 63% as margin reaches 16.6%
Aarti Drugs Limited reported consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) of Rs 137.9 crore in second quarter of fiscal year 2027 (Q2 FY27), up 63% year on year, with an EBITDA margin of 16.6%, 370…
Aarti Drugs Posts 63% EBITDA Jump to ₹138 Crore in Q2 as New Plant Hits Its Stride
Behind every antibiotic strip and diabetes tablet sits a chain of chemicals most people never see. India is called the pharmacy of the world, yet much of that chain still starts outside its borders. The Nifty 50 was trading at 23,895.55,…
Aarti Drugs Q2 FY27 Earnings Shine As Profit Nearly Doubles To ₹82.8 Crore, Revenue Rises 27% To ₹828.8 Crore While 63% EBITDA Growth Signals Stronger Operating Performance
Mumbai: Aarti Drugs reported strong financial results for the second quarter of FY27, with profit after tax (PAT) rising approximately 83 per cent year-on-year to ₹82.8 crore, compared with ₹45.2 crore in the corresponding quarter last…
Aarti Drugs Limited announces Q2, H1 FY27 results
03 Nov 2026, 10:59 PM IST Equity Bulls Stock Report Aarti Drugs Limited INE767A01016 Consolidated Financial Highlights – Q2 FY27 Looking ahead, we are building Aarti Drugs into a more integrated, more diversified and more globally relevant…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- equitybulls.com1
- freepressjournal.in1
- multibagg.ai1
- tradebrains.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.